$29.42
-0.24-0.81%
At Close: -
$29.42
-0.00010.00%
After Hours: Sep 20, 7:59 PM EDT
15 minutes delayed
Comments
Loading...
Latest news for Pfizer (NYSE:PFE) Stock
Pfizer Stock (NYSE: PFE)
Categories: All
Friday, September 20, 2024
Wednesday, September 18, 2024
Tuesday, September 17, 2024
Monday, September 16, 2024
- Beyond The Numbers: 13 Analysts Discuss Pfizer Stock
- Cantor Fitzgerald Reiterates Overweight on Pf...
- DeSantis Administration Cautions Against Pfizer, Moderna mRNA Covid Vaccines for Vulnerable Individuals, Cites Concerns Related To Rare Heart Conditions
- Pfizer Presents Positive Data from Phase 2 St...
- Reported Saturday, Pfizer's BRAFTOVI + MEKTOV...
Friday, September 13, 2024
Thursday, September 12, 2024
Wednesday, September 11, 2024
Monday, September 09, 2024
- Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst
- Why Is Moderna Stock Trading Higher On Monday?
- Cantor Fitzgerald Reiterates Overweight on Pf...
- Relay Therapeutics Advances Towards Pivotal Trial As It Shares Encouraging Breast Cancer Data In Heavily Pretreated Patients
Friday, September 06, 2024
Thursday, September 05, 2024
Wednesday, September 04, 2024
Tuesday, September 03, 2024
- Acepodia Enters Strategic Clinical Collaborat...
- UK, Taiwan Approve Moderna's Updated COVID-19 Shot
- Pfizer And Valneva Partnered Lyme Disease Vaccine Shows Effectiveness As Booster Shot In Mid-Stage Study
- Vaxcyte, Shoals Technologies, Polestar Automotive, Applied Optoelectronics And Other Big Stocks Moving Higher On Tuesday
- Bacterial Infections Vaccine Developer Vaxcyte's Pneumococcal Shot Shows Promise in Mid-Stage Trial, Stock Shoots Higher
- Valneva And Pfizer Announced Further Immunoge...